mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.03 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.37 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |